Equity · Healthcare
CVM
AMEXCel-sci (CVM)
The line runs 1.56 USD on 17 August through 2.29 USD on 2 October, on a scale from 1.0 to 2.5. Days the market did not trade hold the previous close, flat.
- Market cap
- 40.2M USD
- EPS, diluted, year to Sep 2025
- −6.27 USD
- Avg volume
- 4.0K
as of Oct 2, 2026
Have Cel-sci (CVM) insiders bought or sold shares recently?
In the 90 days to 15 Nov 2026, Cel-sci insiders reported 1 open-market purchase and no sales (SEC Form 4).
Form 4, 90 days to 15 Nov 2026, newest reported trade 25 Aug 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 25 Aug 2026 | KERSTEN GEERT RChief Executive Officer | Buy | 100,000 | 138K USD |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 30 Sep 2026 | TALOR EYALChief Scientific Officer | Award | 1,165 | 2K USD |
| 30 Sep 2026 | PRICHEP PATRICIA BChief Financial Officer | Award | 2,082 | 4K USD |
| 30 Sep 2026 | KERSTEN GEERT RChief Executive Officer | Award | 2,621 | 5K USD |
Which funds hold Cel-sci (CVM)?
1 of the 45 institutional funds we track reported a Cel-sci position for the quarter ended 30 Sep 2026 — a combined 970K USD; the latest of those filings landed 12 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 470,869 | 970K USD | −17.7% |
What has been filed or recorded for Cel-sci (CVM)?
The filings we hold for Cel-sci, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 08 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 580 shares | 1K USD notional · 0.003% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 62 shares | 128 USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.47 USD | |
| 30 Jun 2026 | Financials | Total assets | 21.4M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 11.0M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.67 USD | |
| 31 Dec 2025 | Quarterly earnings | Q1 2026 reported | EPS −0.68 USD | |
| 30 Sep 2025 | Annual report | FY 2025 reported | EPS −6.27 USD | |
| 30 Sep 2025 | Financials | Net income | −25.4M USD | fiscal year |
| 30 Sep 2025 | Financials | Diluted EPS | −6.27 USD | fiscal year |
| 30 Jun 2025 | Quarterly earnings | Q3 2025 reported | EPS −1.36 USD | |
| 31 Mar 2025 | Quarterly earnings | Q2 2025 reported | EPS −2.33 USD | |
| 31 Dec 2024 | Quarterly earnings | Q1 2025 reported | EPS −3.25 USD | |
| 30 Sep 2024 | Annual report | FY 2024 reported | EPS −15.31 USD |
What do people ask about Cel-sci (CVM)?
What did Cel-sci shares close at?2.29
Cel-sci closed at 2.29 USD on 2 Oct 2026, up 14.25% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Cel-sci’s market cap?40.2M
Cel-sci is worth 40.2M USD by market value as of 2 Oct 2026, which is the share price times the shares on issue from its SEC filings.
Have Cel-sci insiders bought or sold shares recently?1 purchase
In the 90 days to 15 Nov 2026, Cel-sci insiders reported 1 open-market purchase and no sales (SEC Form 4). A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Cel-sci?1 of 45
1 of the 45 funds we track reported a Cel-sci position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Renaissance Technologies. See Funds
When did Cel-sci last report earnings?−0.47
Cel-sci last reported earnings on 30 Jun 2026 for Q3 2026, with EPS of −0.47 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings